Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Minerva Anestesiol ; 81(12): 1377-83, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25384691

RESUMO

Arginine-vasopressin (AVP) is an important hormone in the regulation of plasma osmolality and blood volume/pressure. In clinical practice it is frequently used in the treatment of septic shock and decompensated cirrhosis. In this review the physiology of AVP and its analogues is presented. In addition the use of AVP in cirrhosis and sepsis is reviewed.


Assuntos
Cirrose Hepática/tratamento farmacológico , Sepse/tratamento farmacológico , Vasoconstritores/uso terapêutico , Vasopressinas/fisiologia , Vasopressinas/uso terapêutico , Arginina Vasopressina/fisiologia , Arginina Vasopressina/uso terapêutico , Humanos , Circulação Hepática/efeitos dos fármacos , Choque Séptico/tratamento farmacológico
2.
J Synchrotron Radiat ; 20(Pt 5): 809-10, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23955047

RESUMO

A set-up for simultaneous imaging and diffraction that yields radiograms with up to 200 frames per second and 5.6 µm effective pixel size is presented. Tomograms and diffractograms are acquired together in 10 s. Two examples illustrate the attractiveness of combining these methods at the EDDI beamline for in situ studies.

3.
Am J Transplant ; 13(1): 184-91, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23126562

RESUMO

Over the last decade the age of liver transplant (LT) recipients and the likelihood of coronary artery disease (CAD) in this population have increased. There are no multicenter studies that have examined the impact of CAD on LT outcomes. In this historical cohort study, we identified adult LT recipients who underwent angiography prior to transplantation at seven institutions over a 12-year period. For each patient we recorded demographic data, recipient and donor risk factors, duration of follow-up, the presence of angiographically proven obstructive CAD (≥50% stenosis) and post-LT survival. Obstructive CAD was present in 151 of 630 patients, the CAD(+) group. Nonobstructive CAD was found in 479 patients, the CAD(-) group. Patient survival was similar for the CAD(+) group (adjusted HR 1.13, CI = [0.79, 1.62], p = 0.493) compared to the CAD(-) group. The CAD(+) patients were further stratified into severe (CADsev, >70% stenosis, n = 96), and moderate CAD (CADmod, 50-70% stenosis, n = 55) groups. Survival for the CADsev (adjusted HR = 1.26, CI = [0.83, 1.91], p = 0.277) and CADmod (adjusted HR = 0.93, CI = [0.52, 1.66], p = 0.797) groups were similar to the CAD(-) group. We conclude that when current CAD treatment strategies are employed prior to transplant, post-LT survival is not significantly different between patients with and without obstructive CAD.


Assuntos
Angiografia Coronária , Doença da Artéria Coronariana/complicações , Transplante de Fígado , Resultado do Tratamento , Idoso , Doença da Artéria Coronariana/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
4.
Transplant Proc ; 44(5): 1336-40, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22664011

RESUMO

BACKGROUND: Protein C is a natural thrombin antagonist produced by hepatocytes. Its levels are low in liver failure and predispose patients to increased risk for thrombosis. Little is known about the relationship between protein C activity and hepatic function after orthotopic liver transplantation (OLT). METHODS: We measured protein C activity of 41 patients undergoing liver transplantation by the Staclot method (normal range, 70%-130%) preoperatively and then daily on postoperative days (POD) 0-5. RESULTS: The mean protein C activity was low before OLT (34.3 ± 4.3%) and inversely correlated with the preoperative Model for End-Stage Liver Disease score (Spearman's r = -0.643; P < .0001). Mean activity increased significantly on POD 1 (58.9 ± 4.5%), and remained above preoperative levels through POD 5. Ten patients developed metabolic liver dysfunction defined by a serum total bilirubin >5 mg/dL on POD 7. These patients had significantly lower protein C activity from POD 3 (47.2 ± 9.6% vs 75.9 ± 5.8%; P = .01) to POD 5. Preoperative protein C activity correlated inversely with the severity of liver failure as indicated by preoperative MELD score. CONCLUSION: Protein C activity recovered rapidly in patients with good allograft function but remained significantly lower in patients who had limited metabolic function as evidenced by increased total bilirubin levels.


Assuntos
Falência Hepática/cirurgia , Transplante de Fígado/efeitos adversos , Fígado/cirurgia , Disfunção Primária do Enxerto/etiologia , Proteína C/metabolismo , Idoso , Bilirrubina/sangue , Biomarcadores/sangue , Coagulação Sanguínea , Testes de Coagulação Sanguínea , Feminino , Humanos , Fígado/metabolismo , Fígado/fisiopatologia , Falência Hepática/sangue , Falência Hepática/diagnóstico , Masculino , Pessoa de Meia-Idade , New York , Valor Preditivo dos Testes , Disfunção Primária do Enxerto/sangue , Disfunção Primária do Enxerto/diagnóstico , Disfunção Primária do Enxerto/fisiopatologia , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento
5.
J Clin Eng ; 18(5): 419-23, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-10129807

RESUMO

Radiology administrators are expected not only to take on the ultimate accountability for meeting the needs and challenges of present day-to-day operations, but also to plan for the future. Computer Aided Facility Management (CAFM), as a tool, enables radiology managers to obtain up-to-date data to manage their services. Using Autocad on a unix-based minicomputer as the graphical base generator and integrating information from a MUMPS-based minicomputer, the CAFM process can define areas to be studied for productivity and life cycle costs. From an analysis of radiology service, management was able to make solid judgement calls for equipment replacement and facility project renovation to effectively manage radiology resources.


Assuntos
Serviço Hospitalar de Engenharia e Manutenção/organização & administração , Serviço Hospitalar de Radiologia/economia , Sistemas de Informação em Radiologia/instrumentação , Controle de Custos/métodos , Sistemas de Gerenciamento de Base de Dados/organização & administração , Eficiência , Florida , Planejamento Hospitalar/métodos , Hospitais de Veteranos/economia , Relações Interdepartamentais , Investimentos em Saúde
6.
Br J Anaesth ; 70(2): 167-72, 1993 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8435261

RESUMO

The vasoconstrictive potencies of lignocaine and mepivacaine were studied in human skin. Lignocaine 0.5%, 0.25% mepivacaine (both plain and mixed with adrenaline or ornipressin), and saline (control) were injected intradermally into skin areas with enhanced perfusion (1% histamine prick). Flux was determined by scanning laser Doppler flowmetry and the size of any eventual pallor was measured. The artificially enhanced flux was increased further by saline, but not altered by the local anaesthetics. Mepivacaine produced a small pallor. Both vasoconstrictors reduced flux significantly and produced a larger pallor. We conclude that both local anaesthetics have only a mild constrictive effect on precapillary vessels. Mepivacaine has, additionally, a constrictor effect on the postcapillary vascular bed, causing pallor. An effective precapillary constriction which reduces the capillary clearance of both local anaesthetics can be achieved only by addition of a vasoconstrictor.


Assuntos
Toxidermias/fisiopatologia , Lidocaína/farmacologia , Mepivacaína/farmacologia , Pele/irrigação sanguínea , Adulto , Epinefrina/farmacologia , Feminino , Histamina , Humanos , Injeções Intradérmicas , Lidocaína/administração & dosagem , Masculino , Mepivacaína/administração & dosagem , Microcirculação/efeitos dos fármacos , Ornipressina/farmacologia , Palidez/induzido quimicamente , Fluxo Sanguíneo Regional/efeitos dos fármacos , Pele/efeitos dos fármacos , Vasoconstrição/efeitos dos fármacos
7.
Stroke ; 23(1): 98-103, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1731428

RESUMO

BACKGROUND AND PURPOSE: Recent findings suggest a key role for platelet activating factor in neuroinjury. For this reason we evaluated the effects of the platelet activating factor antagonist apafant (4-(2-chlorophenyl)-9-methyl-2[3(4-morpholinyl)-3-propanol-1- yl[6H-thieno[3.2-f[[1.2.4]triazolo]4,3-1]]1.4]diazepine on farct volume and local cerebral blood flow following irreversible occlusion of the left middle cerebral artery in rats to assess the direct and vascular components of apafant's action. METHODS: We measured infarct volume 48 hours after middle cerebral artery occlusion. The effect of multiple doses of apafant (30 mg/kg p.o.) was tested in both pretreatment (n = 8) and posttreatment (n = 8) groups. In the pretreatment group apafant was given 30 minutes before and 2, 6, and 18 hours after occlusion. Rats of the posttreatment group received apafant 1, 6, and 18 hours after middle cerebral artery occlusion. We also examined the effect of a single dose of apafant given 30 minutes prior to occlusion (n = 9) on local cerebral blood flow determined 2 hours after middle cerebral artery occlusion. RESULTS: Both regimens of apafant effectively decreased infarct volume. The reduction in cortical infarct volume was 59% (p less than 0.01; H test, U test) when the rats were treated before and after vessel occlusion whereas the decrease was 47% (p less than 0.05; H test, U test) when treatment began 1 hour after occlusion. Apafant did not change local cerebral blood flow after occlusion compared with controls. CONCLUSIONS: We suggest that the cytoprotection afforded by apafant occurs mainly via a direct effect on brain tissue and has no major vascular component.


Assuntos
Azepinas/uso terapêutico , Infarto Cerebral/tratamento farmacológico , Triazóis/uso terapêutico , Animais , Infarto Cerebral/patologia , Infarto Cerebral/fisiopatologia , Circulação Cerebrovascular , Fator de Ativação de Plaquetas/antagonistas & inibidores , Ratos , Ratos Endogâmicos F344
8.
Stroke ; 21(12 Suppl): IV167-70, 1990 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2260143

RESUMO

The present study investigates the effects of the 5-hydroxytryptamine1A agonist ipsapirone on electroencephalography and somatosensory evoked potentials after middle cerebral artery occlusion in the rat. We implanted 17 silver ball electrodes symmetrically distributed over the skull in 14 rats and registered electroencephalography activity and somatosensory evoked potentials before, 1 hour, and 1 week after permanent occlusion of the left middle cerebral artery. Before vessel occlusion, a symmetric distribution of electroencephalography power was seen over both hemispheres. Middle cerebral artery occlusion caused a complete abolishment of electroencephalography power in the frontolateral aspects of the affected hemisphere. When electroencephalographic recordings 7 days after the insult were superimposed with three-dimensional-reconstructed pictures of the infarct, a close correspondence of the extention and spatial orientation was noted. Two negative and two positive peaks were consistently recorded before middle cerebral artery occlusion. In both control and ipsapirone-treated (30 mg/kg i.p. 30 minutes after induction of ischemia) animals, the vessel occlusion caused a severe reduction in amplitudes of somatosensory evoked potentials in all areas under record (p less than 0.05). One week after middle cerebral artery occlusion, amplitudes of somatosensory potentials over the lesioned hemisphere were still significantly (p less than 0.05) lower than preischemic values in the control group. When compared with the corresponding values 1 hour after middle cerebral artery occlusion, an albeit insignificant tendency toward increased amplitudes was observed in most areas under record. By contrast, in ipsapirone-treated animals, significant differences compared with preischemic values were no longer present 1 week after the vessel occlusion.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Potenciais Somatossensoriais Evocados/efeitos dos fármacos , Ataque Isquêmico Transitório/fisiopatologia , Pirimidinas/uso terapêutico , Animais , Artérias Cerebrais/cirurgia , Eletroencefalografia , Feminino , Ataque Isquêmico Transitório/tratamento farmacológico , Ataque Isquêmico Transitório/etiologia , Pirimidinas/farmacologia , Ratos , Ratos Endogâmicos F344 , Serotonina/análogos & derivados
9.
J Clin Microbiol ; 28(8): 1728-33, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2394800

RESUMO

An examination of 23 vancomycin-resistant, streptococcuslike isolates of clinical origin revealed a group of 14 to be related to Leuconostoc lactis (type strain, CIP 102422) on the basis of chemotaxonomic studies. These isolates were initially shown to be atypical by classical biochemical tests. However, they were characterized in particular by their polar lipid patterns by thin-layer chromatography and, additionally, by whole-cell protein patterns by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It is feasible, therefore, that common biochemical tests may continue to serve the purpose of routine identification, even though such isolates were formerly thought to be only of dairy origin.


Assuntos
Leuconostoc/classificação , Aminoácidos/análise , Carboidratos/análise , Eletroforese em Gel de Poliacrilamida , Glicolipídeos/análise , Humanos , Recém-Nascido , Leuconostoc/crescimento & desenvolvimento , Peptidoglicano/análise
10.
S Afr Med J ; 72(3): 205-8, 1987 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-3603316

RESUMO

Morphometric measurements (radiogrammetry) of metacarpal cortical bone from fine-grain radiographic film using a magnifying eyepiece (magnification radiogrammetry) is a simple, inexpensive, reproducible and well-accepted method for assessing appendicular bone mass. Normal values for different countries and ethnic groups must first be established before this method can be applied in clinical practice. The need for normative data in South African coloured and white populations prompted this study.


Assuntos
População Negra , Doenças Ósseas Metabólicas/diagnóstico por imagem , Metacarpo/diagnóstico por imagem , Adolescente , Adulto , Fatores Etários , Idoso , Antropometria , Criança , Feminino , Humanos , Masculino , Métodos , Pessoa de Meia-Idade , Radiografia , Fatores Sexuais , África do Sul , População Branca
12.
S Afr Med J ; 67(1): 31-2, 1985 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-3966183

RESUMO

A case of primary hyperparathyroidism with advanced osteitis fibrosa cystica but without any subperiosteal phalangeal bone resorption is described. A review of this unusual radiological feature is presented. High-detail magnification radiography (microradiography) is advocated for the early diagnosis of bony defects in hyperparathyroidism.


Assuntos
Hiperparatireoidismo/complicações , Metacarpo/diagnóstico por imagem , Osteíte Fibrosa Cística/diagnóstico por imagem , Reabsorção Óssea , Feminino , Humanos , Microrradiografia , Pessoa de Meia-Idade , Osteíte Fibrosa Cística/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...